Sue is extremely friendly and knowledgeable about the entire process
Guidelines suggest monitoring monthly for the first three months and continuing a specific agent when patients lose at least 5% of their initial body weight in that window, absent safety or tolerability concerns
Semaglutides ability to address both weight management and insulin sensitivity makes it a potentially valuable tool in PCOS management, particularly for those who haven't responded well to other treatments
Clean, smart, and effective - so you can shine brighter every day
Here is what each group achieved at 48 weeks
Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, et al